Maternova Appoints Luna M Mehrain, MD, MSc, as Chief Medical Officer

Maternova, Inc., accelerating advances in maternal and infant health through innovative, accessible solutions, today announced the appointment of Luna M. Mehrain, MD, MSc, as Chief Medical Officer.

Dr. Luna Mehrain, an accomplished Obstetrician/Gynecologist and strategic leader in reproductive, maternal and neonatal health, will assess the efficacy, safety and usability of diagnostics and therapeutic medical innovations as potential additions to Maternova’s growing platform. As part of her new role, Dr. Mehrain will also be training the team and Maternova’s partners on clinical bundles that align with international guidelines.

“I am thrilled to welcome Luna to our team. She is a passionate clinician with a proven track record of championing health care for women and babies in resource-limited settings. Her experience with prominent international organizations and expert medical knowledge make her an ideal addition to Maternova as we grow our life-saving product and technology offerings for health practitioners around the world,” said Prakash Veenam, Chief Executive Officer, Maternova.

Dr. Mehrain brings more than 20 years of experience as a physician, as well as medical advisor in development and humanitarian contexts around the world, previously holding positions with Médecins Sans Frontières, Merlin, DAI, Population Services International (PSI) and the International Planned Parenthood Federation (IPPF).

“Maternova is a unique and trusted resource for medical innovations in newborn, obstetrics and reproductive health based on a deep understanding of the issues faced by clinicians and patients in low- and middle-income countries and humanitarian settings,” said Luna Mehrain, MD, MSc, Chief Medical Officer, Maternova. “I’m excited to be part of the Maternova team as we shape the future and make a difference in people’s lives. By accelerating access to effective, evidence-based medical products, we are able to solve challenges preventing worldwide quality health care today that we were unable to solve yesterday.”

Dr. Mehrain earned her MD degree from the University of Dusseldorf, Germany and obtained a Master of Science degree in Sexual and Reproductive Health Research from the London School of Hygiene and Tropical Medicine, UK. In addition to various post-graduate trainings in medicine and public health, she also completed an executive leadership course from Oxford University, UK.

Dr. Mehrain has broad international experience, having held clinical positions in Germany, India, Ethiopia, Pakistan and Sierra Leone and completed clinical internships in New York. As a public health professional, she was based in the head offices of Merlin (London, UK), PSI (Washington D.C.), IPPF (Bangkok, Thailand) and DAI (Jakarta, Indonesia). Within those organizations, she provided technical assistance in program design, implementation, quality assurance and clinical and program training, mainly in Sub-Saharan Africa and Asia, with technical support to Latin America.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.